跳至主要内容
临床试验/NCT01604356
NCT01604356已完成1 期

Acupuncture for the Treatment of Vision Loss Due to Retinitis Pigmentosa

Johns Hopkins University2 个研究点 分布在 1 个国家目标入组 19 人开始时间: 2012年4月最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
19
试验地点
2
主要终点
Dark-adapted (Scotopic) Full-field Stimulus Test

研究概览

简要总结

Retinitis Pigmentosa (RP) patients are interested in trying alternative therapies to attempt to slow, halt or reverse the retinal disease process, and claim success with some approaches such as acupuncture, but this potential treatment has not been put to the test of objective, rigorous scientific study conducted in western society. In this pilot study, the investigators aim to evaluate an acupuncture treatment tailored to the RP population for its feasibility to improve visual function, specifically visual field and dark adaptation. The study results may provide a basis for eye care providers' recommendations to RP patients regarding whether to consider acupuncture as a potential treatment modality. If our hypotheses regarding improvements in vision beyond typical test variability are supported, our future research goals include the conduct of a larger clinical trial with involving randomization and a placebo control for acupuncture in RP.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
10 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of retinitis pigmentosa
  • Best-corrected visual acuity better than 20/400 in at least one eye
  • More than 20% loss of Goldmann Visual Field area (III4e) in at least one eye
  • Able and willing to participate in all study visits in Baltimore for the 8-week program
  • Provide informed consent

排除标准

  • Very severe vision losses in both eyes (e.g., hand motions or light perception only) with difficulty performing the proposed vision tests
  • Vision loss due to ocular diseases other than RP, cystoid macular edema, or cataracts
  • Schedules do not permit participation in all study visits
  • Previous acupuncture treatment in the last 6 months
  • Inability to understand study procedures or communicate responses to visual stimuli in a consistent manner (cognitive impairment)
  • Dementia; Long or short-term memory loss
  • Unable to read or speak English
  • Smoking, substance abuse, or illegal drug use
  • Receiving current psychiatric care (i.e. unstable emotional and mental health status)
  • History of excessive bleeding

结局指标

主要结局

Dark-adapted (Scotopic) Full-field Stimulus Test

时间窗: initial response within 2 weeks after completion of treatment

次要结局

  • Goldmann visual fields(initial response within 2 weeks of treatment completion)
  • PC-based vision tests (visual acuity, contrast sensitivity, visual field)(initial response within 2 weeks of treatment completion)
  • ETDRS visual acuity(initial response within 2 weeks of treatment completion)
  • Pelli-Robson contrast sensitivity(initial response within 2 weeks of treatment completion)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ava Bittner

Principal Investigator

Johns Hopkins University

研究点 (2)

Loading locations...

相似试验